BlackRock Fund Advisors’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$106M Buy
2,857,249
+345,188
+14% +$12.3M 0.02% 1154
2016
Q3
$87.1M Buy
2,512,061
+143,919
+6% +$5.04M 0.02% 1186
2016
Q2
$77M Buy
2,368,142
+85,386
+4% +$2.62M 0.02% 1188
2016
Q1
$65.6M Sell
2,282,756
-24,786
-1% -$660K 0.02% 1262
2015
Q4
$77.1M Buy
2,307,542
+121,743
+6% +$3.79M 0.02% 1166
2015
Q3
$62.2M Sell
2,185,799
-42,699
-2% -$1.49M 0.02% 1277
2015
Q2
$90.3M Buy
2,228,498
+955,401
+75% +$42.9M 0.02% 1081
2015
Q1
$62.6M Buy
1,273,097
+65,981
+5% +$3.06M 0.02% 1356
2014
Q4
$54.9M Buy
+1,207,116
New +$47.4M 0.01% 1399

Other funds holding AVNS

BlackRock Fund Advisors's AVNS Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Avanos Medical (AVNS) stake by 14% in Q4 2016, buying an estimated $12.3M and bringing the position to 2,857,249 shares worth $106M. The position accounts for 0.02% of the portfolio, ranked #1154.

BlackRock Fund Advisors first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. 360 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • BlackRock Fund Advisors held 2,857,249 shares of Avanos Medical worth $106M as of Q4 2016.
  • BlackRock Fund Advisors bought 345,188 Avanos Medical shares in Q4 2016, an estimated $12.3M.
  • Avanos Medical made up 0.02% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1154 holding.
  • BlackRock Fund Advisors first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
  • 360 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.